General MedicationsTOPICALStandard
OXISTAT
OXICONAZOLE NITRATE
Standard Dose
EQ 1% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview OXISTAT is listed in Drugs@FDA under application 020209 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient OXICONAZOLE NITRATE Form and strength LOTION;TOPICAL - EQ 1% BASE Sponsor ANI PHARMS Submission history Latest submission status date: 2022-05-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview OXISTAT is listed in Drugs@FDA under application 020209 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient OXICONAZOLE NITRATE Form and strength LOTION;TOPICAL - EQ 1% BASE Sponsor ANI PHARMS Submission history Latest submission status date: 2022-05-24 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.